OpenAI acquires Ashoka Rajendra’s Orchestra Bio
The American Bazaar
Picture: The American Bazaar
OpenAI has acquired Orchestra Bio, a platform founded by Indian American tech entrepreneur Ashoka Rajendra to help biopharma teams coordinate the complex process of drug development. “We’re bringing Orchestra’s team and technology together with Rosalind, our AI models and tools for life sciences research,” open AI announced Tuesday aiming “to help scientists make discoveries and manage the work needed to turn them into treatments that reach patients sooner.” Rajendra “started Orchestra Bio four years ago to help biotech and pharma teams advance their drug development programs,” he posted on X. “Today, we’re thrilled to share that Orchestra Bio is joining OpenAI to continue our mission at an even greater scale.” Read: Indian American cardiovascular genetics innovator wins 2026 Population Research Prize (October 2, 2026) Terms of the deal were not…
This report was first published by The American Bazaar. What you see here is a brief excerpt. The full text is theirs.
Continue reading at The American Bazaar
